In this five-part series, neurologist Jules Montague and William Miller go into the homes of people with rare dementias, to discover that dementia is not what we think it is. Show more In this ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

category UK pharmacies regulator tightens rules on prescribing obesity drugs 12:11 AM UTC United Kingdomcategory Nigel Farage's right-wing party leads for first time in new UK poll February 3 ...